KIMBERLY MURPHY M.D. NPI 1043212418

NPI Details

Kimberly Murphy, M.D. is an emergency medicine in Lisle, IL with 34 years of experience. The provider is an emergency physician focuses on the immediate decision making and action necessary to prevent death or any further disability both in the pre-hospital setting by directing emergency medical technicians and in the emergency department. The emergency physician provides immediate recognition, evaluation, care, stabilization and disposition of a generally diversified population of adult and pediatric patients in response to acute illness and injury. Kimberly Murphy, M.D. NPI is 1043212418. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: COLLEGE OF MEDICINE AND SURGERY
Graduation Year:1992

The provider's business location address is:

430 WARRENVILLE RD
STE 230
LISLE, IL
ZIP 60532
Phone: (630) 432-6200

The NPI 1043212418 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Adm sarscv2 30mcg trs-sucr 3 (HCPCS:0053A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Automated urinalysis test (HCPCS:81003)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Intravenous injection, bebtelovimab, includes injection and post administration monitoring (HCPCS:M0222)
• Injection of drug or substance into vein (HCPCS:96374)
• Lactic acid level (HCPCS:83605)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected (HCPCS:0241U)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus (HCPCS:87637)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Lipase (fat enzyme) level (HCPCS:83690)
• Amylase (enzyme) level (HCPCS:82150)

The enumeration date for this NPI number is 8/15/2005 and was last updated on 8/16/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.